SG Americas Securities
GSK icon

SG Americas Securities’s GSK GSK Stock Holding History

SG Americas Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Sell
4,154
-7,209
-63% -$381K ﹤0.01% 2762
2026
Q1 		$627K Sell
11,363
-11,905
-51% -$645K ﹤0.01% 2055
2025
Q4 		$1.14M Sell
23,268
-7,683
-25% -$358K ﹤0.01% 1904
2025
Q3 		$1.34M Buy
30,951
+5,030
+19% +$196K ﹤0.01% 1214
2025
Q2 		$995K Buy
25,921
+7,081
+38% +$271K ﹤0.01% 1184
2025
Q1 		$730K Buy
18,840
+7,849
+71% +$287K ﹤0.01% 1457
2024
Q4 		$372K Sell
10,991
-7,782
-41% -$280K ﹤0.01% 1610
2024
Q3 		$767K Buy
18,773
+11,749
+167% +$481K ﹤0.01% 1305
2024
Q2 		$270K Sell
7,024
-10,666
-60% -$449K ﹤0.01% 2017
2024
Q1 		$758K Buy
17,690
+14,466
+449% +$597K ﹤0.01% 1248
2023
Q4 		$119K Buy
+3,224
New +$116K ﹤0.01% 2621
2023
Q1 		– Sell
-7,501
Closed -$264K – 3379
2022
Q4 		$264K Buy
7,501
+3,502
+88% +$117K ﹤0.01% 2017
2022
Q3 		$118K Sell
3,999
-1,751
-30% -$66.4K ﹤0.01% 2733
2022
Q2 		$313K Sell
5,750
-101,048
-95% -$5.58M ﹤0.01% 2356
2022
Q1 		$5.82M Buy
106,798
+96,314
+919% +$5.23M 0.04% 359
2021
Q4 		$578K Buy
10,484
+126
+1% +$6.55K ﹤0.01% 2068
2021
Q3 		$495K Sell
10,358
-385,326
-97% -$19.4M ﹤0.01% 2515
2021
Q2 		$19.7M Buy
395,684
+380,118
+2,442% +$18.3M 0.09% 179
2021
Q1 		$694K Sell
15,566
-10,758
-41% -$488K ﹤0.01% 1782
2020
Q4 		$1.21M Sell
26,324
-10,577
-29% -$486K 0.01% 1433
2020
Q3 		$1.74M Sell
36,901
-39,190
-52% -$1.96M 0.01% 833
2020
Q2 		$3.88M Buy
76,091
+3,564
+5% +$183K 0.03% 469
2020
Q1 		$3.44M Sell
72,527
-72,210
-50% -$3.85M 0.03% 544
2019
Q4 		$8.5M Sell
144,737
-65,681
-31% -$3.65M 0.08% 231
2019
Q3 		$11.2M Sell
210,418
-57,796
-22% -$2.97M 0.09% 221
2019
Q2 		$13.4M Buy
268,214
+215,196
+406% +$10.8M 0.09% 198
2019
Q1 		$2.77M Sell
53,018
-72,888
-58% -$3.64M 0.03% 679
2018
Q4 		$6.01M Buy
125,906
+15,820
+14% +$779K 0.05% 327
2018
Q3 		$5.53M Sell
110,086
-23,279
-17% -$1.18M 0.04% 455
2018
Q2 		$6.72M Buy
133,365
+28,415
+27% +$1.43M 0.06% 322
2018
Q1 		$5.13M Sell
104,950
-88,565
-46% -$4.12M 0.04% 410
2017
Q4 		$8.58M Buy
193,515
+169,690
+712% +$7.84M 0.08% 213
2017
Q3 		$1.21M Buy
+23,825
New +$1.21M 0.01% 1125
2017
Q2 		– Sell
-7,576
Closed -$399K – 3313
2017
Q1 		$399K Buy
+7,576
New +$384K ﹤0.01% 1999
2016
Q3 		– Sell
-5,380
Closed -$291K – 3393
2016
Q2 		$291K Buy
+5,380
New +$283K ﹤0.01% 1950
2015
Q4 		– Sell
-27,258
Closed -$1.31M – 2808
2015
Q3 		$1.31M Sell
27,258
-196,779
-88% -$10.2M 0.01% 759
2015
Q2 		$11.7M Buy
224,037
+202,293
+930% +$11.4M 0.08% 176
2015
Q1 		$1.25M Sell
21,744
-7,824
-26% -$449K 0.01% 1021
2014
Q4 		$1.58M Buy
29,568
+18,755
+173% +$1.05M 0.01% 1046
2014
Q3 		$621K Buy
10,813
+8,978
+489% +$550K ﹤0.01% 1369
2014
Q2 		$123K Sell
1,835
-35,384
-95% -$2.4M ﹤0.01% 2259
2014
Q1 		$2.49M Buy
+37,219
New +$2.52M 0.01% 836

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

SG Americas Securities's GSK Position: Q2 2026 in Review

SG Americas Securities reduced its GSK (GSK) stake by 63% in Q2 2026, selling an estimated $381K and leaving 4,154 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #2762.

SG Americas Securities first reported a position in GSK in Q1 2014 and has held it in 42 quarters since. The position peaked at $19.7M in Q2 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • SG Americas Securities held 4,154 shares of GSK worth $218K as of Q2 2026.
  • SG Americas Securities sold 7,209 GSK shares in Q2 2026, an estimated $381K.
  • GSK made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2762 holding.
  • SG Americas Securities first reported a position in GSK in Q1 2014 and has held it in 42 quarters since.
  • SG Americas Securities's GSK position peaked at $19.7M in Q2 2021.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.